MaMome is founded in 2019, operates from its headquarter in 1 University Plaza New York, US. The company operates in the Software, Healthcare Software sector.
MaMome specializes in Microbiome data analysis, Advanced bioinformatics, Large language model (LLM) utilization, Prenatal care technology, and offers services including Microbiome-based diagnostics, At-home fecal microbiome tests, and Early detection of gestational diabetes.
Total Rounds
US$ 300K
Last Round
US$ 300K
Rounds
1